FY26C1AP30 - NAM-aligned pediatric glioblastoma

Active Definitive Contract Awarded Last action

Contract number
75F40126C00080
Awardee
Awarding agency
Obligated
$884,879

Award facts

Contract value 51% obligated
  • $884,879.12 Current, with exercised options
  • $1,742,521.12 Potential, with all options
Completion date 5% complete
Current and potential, with all options
Contracting staff
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Manassas, VA 20110, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration awarded a $1.74 million definitive contract to American Type Culture Collection for nam-aligned pediatric glioblastoma research on September 1, 2026, with performance through August 31, 2029.

Place of performance is Manassas, Virginia. The contract is firm fixed price with no set-aside applied.

Quick answers

Who was awarded contract 75F40126C00080?

75F40126C00080 was awarded to American Type Culture Collection by Food and Drug Administration (Department of Health and Human Services) on September 1, 2026.

How much is contract 75F40126C00080 worth?

The government has obligated $884,879 on 75F40126C00080. Its potential value, with all options, is $1,742,521.

Was contract 75F40126C00080 competed?

The extent of competition for 75F40126C00080 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award